top of page

Molar Pregnancy (Hydatidiform Mole) – “ครรภ์ไข่ปลาอุก” Follow up β-hCG

Short Recap:

“After uterine evacuation, measure β-hCG weekly until undetectable for three consecutive weeks, then monthly for 6–12 months (usually normalizing by 12 weeks), and use OCPs for contraception—avoiding implants that might mask signs of persistent disease.”


 

1. Introduction

A molar pregnancy (hydatidiform mole) is a gestational trophoblastic disease characterized by abnormal proliferation of the trophoblastic tissue and edematous swelling of chorionic villi. It is divided into complete and partial moles. While in English literature the classic sonographic description is a “snowstorm” or “cluster of grapes,” the Thai term “ครรภ์ไข่ปลาอุก” (Kran Kai Pla Ook) refers specifically to the gross pathological appearance of the evacuated tissue, which resembles fish eggs of the Pla Ook (a type of catfish) rather than the ultrasound image.


 

2. Etiology and Genetics

2.1 Complete Mole

  • Karyotype: Most commonly 46,XX (entirely paternal in origin).

    • Arises when an empty ovum (lacking maternal DNA) is fertilized by:

      1. A single sperm that then duplicates (monospermy), or

      2. Two sperms (dispermy).

  • Fetal/Embryonic Tissue: None. The absence of maternal chromosomes prevents embryo formation.

2.2 Partial Mole

  • Karyotype: Typically triploid (69,XXX; 69,XXY; or 69,XYY).

    • Occurs when a normal ovum is fertilized by two sperms or a single diploid sperm.

  • Fetal/Embryonic Tissue: Some fetal tissue or a fetus may develop, but with multiple anomalies and poor viability.


 

3. Pathophysiology

  • Trophoblastic Overgrowth: Excessive proliferation of syncytiotrophoblasts and cytotrophoblasts.

  • Hydropic Villi: Villi become edematous, fluid-filled, and swollen, giving the characteristic gross appearance of “ไข่ปลาอุก.”

  • High Beta-hCG Production: Abnormal trophoblastic tissue produces markedly elevated hCG, contributing to:

    • Hyperemesis gravidarum (severe nausea/vomiting).

    • Theca-lutein ovarian cysts (due to ovarian hyperstimulation).

    • Hyperthyroidism (hCG can weakly stimulate the thyroid).


 

4. Clinical Presentation

  1. Vaginal Bleeding: Often in the first or early second trimester.

  2. Uterus Size > Dates: Common in complete moles due to excessive trophoblastic tissue.

  3. Excessive Nausea and Vomiting: Correlates with very high beta-hCG.

  4. Possible Hyperthyroidism: Palpitations, heat intolerance, or tachycardia.

  5. No Fetal Heart Tones: In a complete mole, because no viable embryo is present.


 

5. Diagnosis

5.1 Beta-hCG

  • Quantitative Serum Beta-hCG: Levels are often disproportionately high compared to gestational age.

  • Diagnostic and Monitoring Tool: Used to confirm suspicion of molar pregnancy and track treatment response.

5.2 Ultrasound Findings

  • Complete Mole:

    • “Snowstorm” appearance with no identifiable fetus or amniotic sac.

    • Uterus filled with echogenic areas interspersed with numerous cystic spaces.

  • Partial Mole:

    • Enlarged placenta with focal cystic changes.

    • Possible fetus or fetal parts with severe anomalies or growth restriction.

Note: While the ultrasound features in English are often described as “snowstorm” or “cluster of grapes,” the Thai term “ครรภ์ไข่ปลาอุก” emphasizes the gross pathological appearance of the evacuated vesicular tissue.

5.3 Baseline Tests

  • Thyroid Function: Rules out hyperthyroidism from elevated hCG.

  • Liver and Renal Function: Important if chemotherapy is later needed.

  • Complete Blood Count: Evaluates anemia or infection risks before evacuation.

  • Chest X-Ray: Often performed to exclude metastatic gestational trophoblastic neoplasia (GTN), as lungs are a common site of spread.


 

6. Management

6.1 Uterine Evacuation

  • Suction Curettage

    • The preferred method for definitive treatment of molar pregnancy.

    • Often performed under ultrasound guidance to minimize retained products.

  • Ensuring Complete Evacuation

    • In some cases, the standard suction machine may be insufficient to remove all adherent molar tissue.

    • High-Powered Vacuum Aspiration (typically in the Labor Room) can help ensure more complete evacuation, reducing the risk of hemorrhage or retained mole.

6.2 Rh (D) Immunoglobulin

  • For Rh-Negative Patients: Administer anti-D immunoglobulin post-evacuation to prevent isoimmunization.

6.3 Histopathological Confirmation

  • Tissue Analysis: All evacuated products are sent for pathology to confirm the diagnosis of hydatidiform mole (complete vs. partial) and rule out invasive disease.


 

7. Follow-Up and Beta-hCG Monitoring

7.1 Rationale

  • Continuous monitoring is essential to detect persistent gestational trophoblastic neoplasia (GTN) early.

7.2 Protocol

  1. Weekly Beta-hCG:

    • Until undetectable for at least 3 consecutive weeks.

  2. Monthly Beta-hCG:

    • Once hCG is undetectable, continue monthly measurements for 6–12 months.

  3. Expected Decline:

    • Beta-hCG has a half-life of ~1.5–2 days; by 12 weeks post-evacuation, levels should generally be undetectable if regression is normal.

7.3 Indicators of GTN

  • Rising or Plateauing hCG: Suggests persistent trophoblastic disease, necessitating further evaluation for GTN.

  • FIGO Scoring System (if GTN is suspected) helps guide chemotherapy regimens (e.g., single-agent methotrexate or actinomycin-D).


 

8. Contraception During Follow-Up

8.1 Importance

  • Avoid Pregnancy to differentiate a true rise in hCG from persistent trophoblastic disease vs. a new pregnancy.

8.2 Recommended Methods

  • Oral Contraceptive Pills (OCPs):

    • Safe and do not interfere with hCG measurements.

    • Facilitate clear detection of abnormal bleeding.

8.3 Contraindicated Methods

  • Implantable Contraceptives (e.g., progestin implants):

    • Can cause irregular bleeding, potentially confounding the clinical picture or hCG trend interpretation.


 

9. Additional Considerations and Risk Factors

  1. Age: Advanced maternal age increases the risk of a molar pregnancy.

  2. Prior Molar Pregnancy: History of one molar pregnancy raises the risk of recurrence.

  3. Nutritional Deficiencies: Some studies suggest that dietary factors (e.g., Vitamin A deficiency) may play a role, though data are limited.


 

10. Summary and Practical Points

  1. Terminology

    • In Thai, “ครรภ์ไข่ปลาอุก” underscores the gross vesicular appearance (resembling fish eggs) seen when the molar tissue is evacuated, not specifically the ultrasound image.

    • In English, sonographic descriptions such as “snowstorm” or “cluster of grapes” are more common.

  2. Diagnosis

    • Extremely high beta-hCG levels and characteristic ultrasound findings.

    • Differentiate between complete and partial mole via histopathology.

  3. Definitive Treatment

    • Suction Curettage with thorough evacuation.

    • Pathology to confirm molar pregnancy type.

  4. Follow-Up

    • Beta-hCG weekly until undetectable, then monthly for 6–12 months.

    • Early detection of GTN ensures prompt chemotherapy if needed.

  5. Contraception

    • OCPs recommended to prevent pregnancy and allow accurate hCG surveillance.

    • Avoid implants or IUDs that may cause irregular bleeding.

  6. Long-Term Outlook

    • The majority of patients achieve complete recovery with proper evacuation and follow-up.

    • A small proportion develop persistent trophoblastic disease requiring chemotherapy, which is highly effective when initiated promptly.


 

Conclusion

Molar pregnancy, or “ครรภ์ไข่ปลาอุก” in Thai, remains a critical condition requiring early recognition, comprehensive evacuation, and vigilant follow-up. While ultrasound features often guide the initial diagnosis, it is the gross pathology of hydropic villi that inspires the descriptive Thai name. By understanding the genetic and clinical distinctions between complete and partial moles, adhering to meticulous surgical and follow-up protocols, and maintaining effective contraception, clinicians can optimize patient outcomes and detect gestational trophoblastic neoplasia at its earliest and most treatable stage.

Recent Posts

See All

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
Post: Blog2_Post

Message for International Readers
Understanding My Medical Context in Thailand

By Uniqcret, M.D.
 

Dear readers,
 

My name is Uniqcret, which is my pen name used in all my medical writings. I am a Doctor of Medicine trained and currently practicing in Thailand, a developing country in Southeast Asia.
 

The medical training environment in Thailand is vastly different from that of Western countries. Our education system heavily emphasizes rote memorization—those who excel are often seen as "walking encyclopedias." Unfortunately, those who question, critically analyze, or solve problems efficiently may sometimes be overlooked, despite having exceptional clinical thinking skills.
 

One key difference is in patient access. In Thailand, patients can walk directly into tertiary care centers without going through a referral system or primary care gatekeeping. This creates an intense clinical workload for doctors and trainees alike. From the age of 20, I was already seeing real patients, performing procedures, and assisting in operations—not in simulations, but in live clinical situations. Long work hours, sometimes exceeding 48 hours without sleep, are considered normal for young doctors here.
 

Many of the insights I share are based on first-hand experiences, feedback from attending physicians, and real clinical practice. In our culture, teaching often involves intense feedback—what we call "โดนซอย" (being sliced). While this may seem harsh, it pushes us to grow stronger, think faster, and become more capable under pressure. You could say our motto is “no pain, no gain.”
 

Please be aware that while my articles may contain clinically accurate insights, they are not always suitable as direct references for academic papers, as some content is generated through AI support based on my knowledge and clinical exposure. If you wish to use the content for academic or clinical reference, I strongly recommend cross-verifying it with high-quality sources or databases. You may even copy sections of my articles into AI tools or search engines to find original sources for further reading.
 

I believe that my knowledge—built from real clinical experience in a high-intensity, under-resourced healthcare system—can offer valuable perspectives that are hard to find in textbooks. Whether you're a student, clinician, or educator, I hope my content adds insight and value to your journey.
 

With respect and solidarity,

Uniqcret, M.D.

Physician | Educator | Writer
Thailand

bottom of page